JDMRX
Price
$122.97
Change
-$3.94 (-3.10%)
Updated
Dec 18 closing price
KMKAX
Price
$77.04
Change
-$4.82 (-5.89%)
Updated
Dec 18 closing price
Ad is loading...

JDMRX vs KMKAX

Header iconJDMRX vs KMKAX Comparison
Open Charts JDMRX vs KMKAXBanner chart's image
Janus Henderson Enterprise R
Price$122.97
Change-$3.94 (-3.10%)
VolumeN/A
CapitalizationN/A
Kinetics Market Opportunities Adv A
Price$77.04
Change-$4.82 (-5.89%)
VolumeN/A
CapitalizationN/A
JDMRX vs KMKAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDMRX vs. KMKAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDMRX is a Hold and KMKAX is a Hold.

FUNDAMENTALS
Fundamentals
JDMRX has more cash in the bank: 23.9B vs. KMKAX (241M). KMKAX pays higher dividends than JDMRX: KMKAX (0.58) vs JDMRX (0.00). JDMRX was incepted earlier than KMKAX: JDMRX (15 years) vs KMKAX (19 years). JDMRX is a more actively managed with annual turnover of: 14.00 vs. KMKAX (5.00). JDMRX (2500) and KMKAX (2500) have matching initial minimum investment requirements. KMKAX annual gain was more profitable for investors over the last year : 99.45 vs. JDMRX (12.52). KMKAX return over 5 years is better than : 224.74 vs. JDMRX (-3.30).
JDMRXKMKAXJDMRX / KMKAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years19 years-
Gain YTD10.67798.97911%
Front LoadN/AN/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets23.9B241M9,917%
Annual Yield % from dividends0.000.58-
Returns for 1 year12.5299.4513%
Returns for 3 years-21.71112.33-19%
Returns for 5 years-3.30224.74-1%
Returns for 10 years52.46405.4013%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL253.482.44
+0.97%
Apple
PLSE19.240.07
+0.37%
Pulse Biosciences
TSLX20.690.04
+0.19%
Sixth Street Specialty Lending
KPTI0.67N/A
-0.51%
Karyopharm Therapeutics
SF107.18-2.28
-2.08%
Stifel Financial Corp